berberine has been researched along with Diathesis in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Trimethylamine-N-oxide (TMAO), a derivative from the gut microbiota metabolite trimethylamine (TMA), has been identified to be an independent risk factor for promoting atherosclerosis." | 8.02 | Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome. ( Du, Y; Hong, B; Jiang, J; Jiang, Z; Li, X; Su, C; Wang, L; Yang, M; Yang, Y; Zhang, J; Zhang, X; Zhang, Y, 2021) |
| "Berberine is a plant alkaloid possessing scientifically determined mechanisms of the prevention of the development of atherosclerosis, type 2 diabetes, and obesity, as well as cardiovascular complications and cancer." | 6.82 | Berberine, a Herbal Metabolite in the Metabolic Syndrome: The Risk Factors, Course, and Consequences of the Disease. ( Nowak, R; Och, A; Och, M; Podgórska, D; Podgórski, R, 2022) |
| "Trimethylamine-N-oxide (TMAO), a derivative from the gut microbiota metabolite trimethylamine (TMA), has been identified to be an independent risk factor for promoting atherosclerosis." | 4.02 | Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome. ( Du, Y; Hong, B; Jiang, J; Jiang, Z; Li, X; Su, C; Wang, L; Yang, M; Yang, Y; Zhang, J; Zhang, X; Zhang, Y, 2021) |
| "Berberine is a plant alkaloid possessing scientifically determined mechanisms of the prevention of the development of atherosclerosis, type 2 diabetes, and obesity, as well as cardiovascular complications and cancer." | 2.82 | Berberine, a Herbal Metabolite in the Metabolic Syndrome: The Risk Factors, Course, and Consequences of the Disease. ( Nowak, R; Och, A; Och, M; Podgórska, D; Podgórski, R, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Och, A | 1 |
| Och, M | 1 |
| Nowak, R | 1 |
| Podgórska, D | 1 |
| Podgórski, R | 1 |
| Li, X | 1 |
| Su, C | 1 |
| Jiang, Z | 1 |
| Yang, Y | 1 |
| Zhang, Y | 1 |
| Yang, M | 1 |
| Zhang, X | 1 |
| Du, Y | 1 |
| Zhang, J | 1 |
| Wang, L | 1 |
| Jiang, J | 1 |
| Hong, B | 1 |
1 review available for berberine and Diathesis
| Article | Year |
|---|---|
Berberine, a Herbal Metabolite in the Metabolic Syndrome: The Risk Factors, Course, and Consequences of the Disease.
Topics: Animals; Anti-Inflammatory Agents; Anticholesteremic Agents; Antineoplastic Agents; Antipsychotic Ag | 2022 |
1 other study available for berberine and Diathesis
| Article | Year |
|---|---|
Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome.
Topics: Animals; Atherosclerosis; Berberine; Choline; Diet; Disease Models, Animal; Disease Susceptibility; | 2021 |